Multiple sclerosis: from cure to care.

Area of Science:

• Neurology
• Immunology

Background:

• Multiple sclerosis (MS) is a prevalent chronic neurological condition affecting young adults.
• The disease's etiology remains unknown, presenting diverse clinical courses, symptoms, and limited effective treatments, contributing to its complexity.
• MS exhibits heterogeneity in pathophysiology, encompassing inflammatory and neurodegenerative processes, leading to relapses and progressive disability.

Purpose of the Study:

• To highlight the multifaceted nature of multiple sclerosis.
• To underscore the challenges in understanding and treating MS due to its heterogeneity.
• To emphasize the need for personalized treatment strategies in managing MS.

Main Methods:

• Review of existing literature on multiple sclerosis pathophysiology and clinical presentation.
• Analysis of disease heterogeneity across various aspects including etiology, course, symptoms, and treatment response.
• Examination of genetic, radiological, and pathological factors influencing MS.

Main Results:

• MS presents with a wide spectrum of symptoms, including weakness, sensory disturbances, fatigue, cognitive impairment, and bladder issues.
• Clinical manifestations do not always correlate with radiological or pathological findings.
• Disease-modifying drugs show variable efficacy among individuals, influenced by genetic heterogeneity.

Conclusions:

• The complexity of MS stems from its heterogeneous nature in pathology, clinical presentation, and individual disease progression.
• Current treatments offer variable benefits, necessitating a move towards personalized medicine.
• The primary future challenge is to deliver the right treatment to the right MS patient at the optimal time.